Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2019, Vol. 33 ›› Issue (4): 31-35.doi: 10.6040/j.issn.1673-3770.1.2019.031
• Clinical Research • Previous Articles Next Articles
Zelei HUANG1,Qi SONG2,Xiuying LU2,Lanzhen CUI2,Xiaoming LI2,*()
CLC Number:
1 | Heng PS , Irfan M . Hypopharyngeal cancer masquerading as a thyroid mass[J]. Med J Malaysia, 2016, 71 (6): 360- 362. |
2 |
Takes RP , Strojan P , Silver CE , et al. Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery[J]. Head Neck, 2012, 34 (2): 270- 281.
doi: 10.1002/hed.21613 |
3 |
Cooper JS , Porter K , Mallin K , et al. National Cancer Database report on cancer of the head and neck: 10-year update[J]. Head Neck, 2009, 31 (6): 748- 758.
doi: 10.1002/hed.21022 |
4 |
Day D , Hansen AR , Siu LL . Hypopharyngeal cancer: looking back, moving forward[J]. Curr Oncol, 2016, 23 (4): 221- 222.
doi: 10.3747/co.23.3242 |
5 |
Wang DC , Meng G , Zheng MH , et al. The glutaminase-1 inhibitor 968 enhances dihydroartemisinin-mediated antitumor efficacy in hepatocellular carcinoma cells[J]. PLoS One, 2016, 11 (11): e0166423.
doi: 10.1371/journal.pone.0166423 |
6 |
Jiang J , Geng GJ , Yu XY , et al. Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis[J]. Oncotarget, 2016, 7 (52): 87271- 87283.
doi: 10.18632/oncotarget.13536.10.1007/s10637-010-9481-8 |
7 |
Lu JJ , Chen SM , Zhang XW , et al. The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells[J]. Invest New Drugs, 2011, 29 (6): 1276- 1283.
doi: 10.1007/s10637-010-9481-8 |
8 |
Zhang SQ , Ma YN , Jiang JT , et al. Inhibition of urokinase-type plasminogen activator expression by dihydroartemisinin in breast cancer cells[J]. Oncol Lett, 2014, 7 (5): 1375- 1380.
doi: 10.3892/ol.2014.1918 |
9 |
Hu CJ , Zhou L , Cai Y . Dihydroartemisinin induces apoptosis of cervical cancer cells via upregulation of RKIP and downregulation of bcl-2[J]. Cancer Biol Ther, 2014, 15 (3): 279- 288.
doi: 10.4161/cbt.27223 |
10 |
Xu G , Zou WQ , Du SJ , et al. Mechanism of dihydroartemisinin-induced apoptosis in prostate cancer PC3 cells: An iTRAQ-based proteomic analysis[J]. Life Sci, 2016, 157: 1- 11.
doi: 10.1016/j.lfs.2016.05.033 |
11 |
Jia LF , Song Q , Zhou CY , et al. Dihydroartemisinin as a putative STAT3 inhibitor, suppresses the growth of head and neck squamous cell carcinoma by targeting Jak2/STAT3 signaling[J]. PLoS One, 2016, 11 (1): e0147157.
doi: 10.1371/journal.pone.0147157 |
12 |
贾立峰, 李晓明, 申宇鹏, 等. 双氢青蒿素对下咽癌Fadu细胞凋亡的影响[J]. 临床耳鼻咽喉头颈外科杂志, 2016, 30 (21): 1685- 1688.
doi: 10.13201/j.issn.1001-1781.2016.21.005 |
JIA Lifeng , LI Xiaoming , SHEN Yupeng , et al. Effects of dihydroartemisinin on the apoptosis of Fadu cells[J]. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2016, 30 (21): 1685- 1688.
doi: 10.13201/j.issn.1001-1781.2016.21.005 |
|
13 |
Pi LH , Li XM , Song Q , et al. Knockdown of glucose-regulated protein 78 abrogates chemoresistance of hypopharyngeal carcinoma cells to cisplatin induced by unfolded protein in response to severe hypoxia[J]. Oncol Lett, 2014, 7 (3): 685- 692.
doi: 10.3892/ol.2013.1753 |
14 |
Teng Y , Ross JL , Cowell JK . The involvement of JAK-STAT3 in cell motility, invasion, and metastasis[J]. JAKSTAT, 2014, 3 (1): e28086.
doi: 10.4161/jkst.28086 |
15 |
Kamran MZ , Patil P , Gude RP . Role of STAT3 in cancer metastasis and translational advances[J]. Biomed Res Int, 2013, 2013: 421821.
doi: 10.1155/2013/421821 |
16 |
Lopez R , Arumugam A , Joseph R , et al. Hyperglycemia enhances the proliferation of non-tumorigenic and malignant mammary epithelial cells through increased leptin/IGF1R signaling and activation of AKT/mTOR[J]. PLoS One, 2013, 8 (11): e79708.
doi: 10.1371/journal.pone.0079708 |
17 |
Wallbillich JJ , Josyula S , Saini U , et al. High glucose-mediated STAT3 activation in endometrial cancer is inhibited by metformin: therapeutic implications for endometrial cancer[J]. PLoS One, 2017, 12 (1): e0170318.
doi: 10.1371/journal.pone.0170318 |
18 |
Kaira K , Toyoda M , Shimizu A , et al. Prognostic significance of GRP78/BiP expression in patients with Stage Ⅲ/Ⅳ hypopharyngeal squamous cell carcinoma[J]. Neoplasma, 2016, 63 (3): 477- 483.
doi: 10.4149/319_151002N513 |
19 |
Niu ZY , Wang MY , Zhou L , et al. Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer[J]. Sci Rep, 2015, 5: 16067.
doi: 10.1038/srep16067 |
20 |
Wang XH , Liu BR , Qu B , et al. Silencing STAT3 may inhibit cell growth through regulating signaling pathway, telomerase, cell cycle, apoptosis and angiogenesis in hepatocellular carcinoma: potential uses for gene therapy[J]. Neoplasma, 2011, 58 (2): 158- 171.
doi: 10.4149/neo_2011_02_158 |
[1] | . Curcumin combined with resveratrol enhances their anti-tumoral effects in the head and neck carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(2): 67-72. |
[2] | LI Xiaoming, SONG Qi, LI Hongxia, TAO Zhenfeng, SHEN Yupeng, XIAO Shufen. Reconstruction of hypopharyngeal defects after ablation of advanced head and neck squamous carcinoma involving hypophaynx with pectoralis major myocutaneous flap. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(3): 4-9. |
[3] | LI Wenming, WEI Dongmin, SUN Ruijie, QIAN Ye, LIU Dayu, XIE Guang, LEI Dapeng, PAN Xinliang. Surgical treatment of hypopharyngeal cancer with cervical esophageal invasion. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(3): 15-19. |
[4] | DONG Pin, YING Xinjiang, CHEN Xinwei, DENG Zhihong, ZHANG Shaoqiang, YU Ziwei, JIN Bin, SUN Zhenfeng, XIE Jin, ZHU Jiangcai. Preliminary clinical analysis of neo-adjuvant chemotherapy with nimotuzumab plus nedaplatin and fluorouracil in hypopharyngeal squamous cell carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(3): 10-14. |
[5] | HU Wenliang, ZHENG Yanqiu, CUI Xiaobo, CUI Yanru, SUN Yuanhao. Bioinformatic screening of differentially expressed protein kinases and their inhibitors in hypopharyngeal cancer. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(3): 24-28. |
[6] | ZHENG Li-you. null [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(6): 31-33. |
[7] | LIANG Hui1,2, PAN Xinliang1, MA Chao3, WANG Qirong2, HAN Fei2, CUI Zhaoyang2. Invasion of the CD133-positive cells in FADU cell line [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(2): 5-7. |
|